Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

BACKGROUND: Immune checkpoint inhibition has dramatically transformed the treatment of malignant melanoma. With increasing use, their unique spectrum of immune-mediated toxicity has become apparent. CASE PRESENTATION: We describe a case of sequential immune-related adverse events (irAEs) in a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, N., Jacob, J., Househ, Z., Shiner, E., Baird, L., Soudy, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740018/
https://www.ncbi.nlm.nih.gov/pubmed/31511075
http://dx.doi.org/10.1186/s40425-019-0727-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740018/
https://www.ncbi.nlm.nih.gov/pubmed/31511075
http://dx.doi.org/10.1186/s40425-019-0727-5

Ejemplares similares